U.S. private equity firm Bain Capital has bought Mitsubishi Tanabe Pharma in a deal worth 510 billion yen ($3.4 billion), ...

Japan's Mitsubishi Corp took a 52.2 billion yen ($342.4 million) impairment charge on its domestic offshore wind projects in ...

Mitsubishi Corp on Monday said it is reviewing how to proceed with its offshore wind projects in Japan given a "significantly ...

Japan's Mitsubishi Corp posted on Thursday a 19% increase in nine-month net profit to December to 827.4 billion yen ($5.43 ...

Tanabe Pharma focuses on therapeutic areas such as immunology and inflammation, vaccines, diabetes, and central nervous ...

Despite production ending in 1986, the aircraft is still flying around today and is popular due to its dependability and ...

Bain Capital is nearing a deal to buy Mitsubishi Chemical Group Corp.’s pharmaceutical unit, people familiar with the matter ...

Mitsubishi Corp. is reviewing business plans for three Japanese offshore wind power projects following macroeconomic changes, ...

Mitsubishi Motors is facing a tough financial year, with the company slashing its net profit forecast by a staggering 76%.

Mitsubishi Corp has recorded an impairment charge of Y52.2bn ($342.4m) on its offshore wind projects in Japan.

Mitsubishi Tanabe saw core operating income slide 61% to 56.2 billion yen ($370 million) in the last financial year. Private equity-led buyouts are booming in Japan as companies increasingly carve ...

TOKYO: Japan's Mitsubishi Corp took a ¥66.8 billion (US$438.61 million) impairment charge on its domestic offshore wind ...